期刊
EUROPEAN NEUROPSYCHOPHARMACOLOGY
卷 24, 期 6, 页码 919-929出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.euroneuro.2014.02.004
关键词
5-HT; Autism; Biomarker; Endophenotype; Meta-analysis
资金
- Italian Ministry for University, Scientific Research and Technology [2006058195, 2008BACT54_002]
- Italian Ministry of Health [RFPS-2007-5-640174, RF-2011-02350537]
- Fondazione Gaetano e Mafalda Luce (Milan, Italy)
- Autism Aid ONLUS (Naples, Italy)
- Autism Speaks (Princeton, NJ)
- Autism Research Institute (San Diego, CA)
- Innovative Medicines Initiative Joint Undertaking (EU-AIMS) [115300]
Elevated blood serotonin (5-HT) levels were the first biomarker identified in autism research. Many studies have contrasted blood 5-HT levels in autistic patients and controls, but different measurement protocols, technologies, and biomaterials have been used through the years. We performed a systematic review and meta-analysis to provide an overall estimate of effect size and between-study heterogeneity, while verifying whether and to what extent different methodological approaches influence the strength of this association. Our literature search strategy identified 551 papers, from which 22 studies providing patient and control blood 5-HT values were selected for meta-analysis. Significantly higher 5-HT levels in autistic patients compared to controls were recorded both in whole blood (WB) [O.R.=4.6; (3.1-5.2); P=1.0 x 10(-12)], and in platelet-rich plasma (PRP) [O.R.=2.6 (1.8-3.9); P=2.7 x 10(-7)]. Predictably, studies measuring 5-HT levels in platelet-poor plasma (PPP) yielded no significant group difference [O.R.=0.54 (0.2-2-0); P=0.36]. Altogether, elevated 5-HT blood levels were recorded in 28.3% in WB and 22.5% in PRP samples of autistic individuals, as reported in 15 and 4 studies, respectively. Studies employing HPLC vs fluorometric assays yield similar cumulative effect sizes, but the former display much lower variability. In summary, despite some limitations mainly due to small study sample sizes, our results significantly reinforce the reliability of elevated 5-HT blood levels as a biomarker in ASD, providing practical indications potentially useful for its inclusion in multimarker diagnostic panels for clinical use. (C) 2014 Elsevier B.V. and ECNP. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据